Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Colorectal Neoplasms 498Rectal Neoplasms 268Colonic Neoplasms 219Pancreatic Neoplasms 190Stomach Neoplasms 183Esophageal Neoplasms 135Breast Neoplasms 119Neoplasm Metastasis 117Squamous Cell Carcinoma of Head and Neck 95Head and Neck Neoplasms 92Neoplasms 90Adenocarcinoma Of Esophagus 67Esophageal Squamous Cell Carcinoma 62Carcinoma, Hepatocellular 56Adenocarcinoma 40Nasopharyngeal Carcinoma 35Cholangiocarcinoma 33Biliary Tract Neoplasms 27Anus Neoplasms 26Gastrointestinal Neoplasms 25Carcinoma, Squamous Cell 25Carcinoma, Non-Small-Cell Lung 25Keratosis, Actinic 23Gallbladder Neoplasms 22Liver Neoplasms 21Urinary Bladder Neoplasms 20Parkinson Disease 4, Autosomal Dominant Lewy Body 20Bile Duct Neoplasms 19Ovarian Neoplasms 16Carcinoma 16

Interventions

Radiotherapy 2Docetaxel 2Cisplatin 2Carboplatin 2toripalimab 1enasidenib 1dehydroftorafur 1Radiotherapy, Intensity-Modulated 1Radiation 1Protons 1Platinum 1Fluorouracil 1Chemoradiotherapy 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Sinonasal undifferentiated carcinoma × Fluorouracil × Clear all
NCT00707473 2026-03-05

Docetaxel, Cisplatin and Fluorouracil in Treating Patients With Previously Untreated Stage II-IV Nasal Cavity and Paranasal Sinus Cancer

M.D. Anderson Cancer Center

Phase 2 Active not recruiting
31 enrolled

Sinonasal undifferentiated carcinoma, Paranasal Sinus Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡